A carregar...
Asenapine versus placebo for schizophrenia
BACKGROUND: Schizophrenia is a highly prevalent and chronic disorder that comprises a wide range of symptomatology. Asenapine is a recently developed atypical antipsychotic that is approved by the US Food and Drug Administration (FDA) for the treatment of schizophrenia. OBJECTIVES: To determine the...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2015
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6464872/ https://ncbi.nlm.nih.gov/pubmed/26599405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011458.pub2 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|